Steen Olivier D, Bos Martje, van Ockenburg Sonja L, Zhou Yiling, Nolte Ilja M, Snieder Harold, Kendler Kenneth, Rosmalen Judith G M, van Loo Hanna M
Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
BMC Med. 2025 Aug 11;23(1):469. doi: 10.1186/s12916-025-04293-7.
BACKGROUND: Functional disorders share familial risk with internalizing disorders such as generalized anxiety disorder and depression, and are comorbid with cardiometabolic and immune-related diseases. We investigated whether functional and internalizing disorders co-aggregate with these diseases in families to gain insight into the aetiology of functional and internalizing disorders. METHODS: We included 166,774 subjects (aged 3-94), from the population-based Lifelines Cohort Study, a Dutch general population cohort. We defined cases for three functional disorders (myalgic encephalomyelitis/chronic fatigue syndrome; ME/CFS, fibromyalgia, and irritable bowel syndrome; IBS), two internalizing disorders (major depressive disorder; MDD and generalized anxiety disorder; GAD), cardiometabolic diseases (obesity, metabolic associated steatotic liver disease, type 2 diabetes, hypertension and cardiovascular disease) and immune-related diseases (composite measures of auto-immune disease and atopy). We used logistic regression to model the prevalence of these disorders in the general population and in participants with affected relatives. Using these prevalence estimates, we assessed familial co-aggregation with (1) recurrence risk ratios (λ), and (2) familial correlations (r). RESULTS: All functional and internalizing disorders co-aggregated with immune-related diseases (λ range 1.06-1.24). ME/CFS, FM, and MDD co-aggregated with most cardiometabolic diseases (λ range 1.00-1.23). MDD, fibromyalgia, and ME/CFS showed similar familial correlation patterns with both disease groups (r range 0.12-0.44), while patterns of IBS and GAD were more variable. CONCLUSIONS: Internalizing and functional disorders share familial risk with immune-related and cardiometabolic diseases. This suggests that risk factors relevant to immune-related and cardiometabolic diseases may also be relevant for FDs. Future studies should investigate such risk factors to identify novel treatment targets.
背景:功能性障碍与内化性障碍(如广泛性焦虑症和抑郁症)具有家族风险,并且与心脏代谢和免疫相关疾病共病。我们调查了功能性障碍和内化性障碍在家庭中是否与这些疾病共同聚集,以深入了解功能性障碍和内化性障碍的病因。 方法:我们纳入了来自荷兰普通人群队列“生命线队列研究”的166,774名受试者(年龄3 - 94岁)。我们定义了三种功能性障碍(肌痛性脑脊髓炎/慢性疲劳综合征;ME/CFS、纤维肌痛和肠易激综合征;IBS)、两种内化性障碍(重度抑郁症;MDD和广泛性焦虑症;GAD)、心脏代谢疾病(肥胖、代谢相关脂肪性肝病、2型糖尿病、高血压和心血管疾病)以及免疫相关疾病(自身免疫性疾病和特应性的综合指标)的病例。我们使用逻辑回归对这些障碍在普通人群和有患病亲属的参与者中的患病率进行建模。利用这些患病率估计值,我们评估了家族性共同聚集情况,包括(1)复发风险比(λ)和(2)家族相关性(r)。 结果:所有功能性和内化性障碍都与免疫相关疾病共同聚集(λ范围为1.06 - 1.24)。ME/CFS、纤维肌痛和MDD与大多数心脏代谢疾病共同聚集(λ范围为1.00 - 1.23)。MDD、纤维肌痛和ME/CFS在两个疾病组中显示出相似的家族相关性模式(r范围为0.12 - 0.44),而IBS和GAD的模式则更具变异性。 结论:内化性障碍和功能性障碍与免疫相关和心脏代谢疾病具有家族风险。这表明与免疫相关和心脏代谢疾病相关的危险因素可能也与功能性障碍有关。未来的研究应调查此类危险因素,以确定新的治疗靶点。
Cochrane Database Syst Rev. 2024-12-19
Cochrane Database Syst Rev. 2017-3-23
Cochrane Database Syst Rev. 2016-6-2
Cochrane Database Syst Rev. 2017-4-25
Cochrane Database Syst Rev. 2016-12-20
Cochrane Database Syst Rev. 2016-6-24
Cell Mol Gastroenterol Hepatol. 2024
Eur J Epidemiol. 2024-6
Arthritis Rheumatol. 2024-2